about
ChemotherapeuticsValidation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.Discovery and development of new antimicrobial agents.Antibacterial activity of cinoxacin in vitro.Efficacy of cinoxacin in urinary tract infectionsPharmacology of cinoxacin in humans.Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.Cinoxacin: pharmacokinetics and the effect of probenecid.Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.Cinoxacin: effectiveness against experimental pyelonephritis in rats.A review of the antimicrobial activity of the fluoroquinolones.Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli.In vitro activity of cinoxacin, ampicillin, and chloramphenicol against Shigella and nontyphoid SalmonellaInfluence of probenecid on serum levels and urinary excretion of cinoxacinCinoxacin: in vitro antibacterial studies of a new synthetic organic acid.In vitro activity of cinoxacin, an organic acid antibacterial.In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
P2860
Q30047670-E8302CA0-383E-4AE0-B2C4-DF2384455F84Q33981143-3258883D-7C0B-4EF3-8896-5809D5D7295DQ34371891-A6EC5B1C-E264-46E6-9D93-CB84FCF7243DQ34510517-E135FA47-166B-408E-925D-915408027F9AQ34531486-1A53D3E1-291A-4617-B7AF-10D6A9231B68Q34697653-84972D94-7ACA-4DF5-A1A5-4E23ABB2AC4FQ34712753-D36BCB38-025E-4C7B-A803-FB44A33CFE84Q34715432-398EDD15-F32B-4797-B370-4E8FE18C2F7FQ34732646-56E52E61-89CE-4753-9886-0347E759062BQ35657639-32B9CABC-3D87-419C-968B-95413AF377ECQ37834318-E47EDDE6-D3F9-44DB-B2D3-16AEBC678454Q39129810-8A29E2B9-6C01-4AAA-A0F4-1E8CE448595AQ40087129-8F4B0642-1C55-44E6-B3F9-7941FC3FFDEFQ40617086-50034BA6-5C25-4152-B969-53C031B2EE55Q40620199-4D86F745-60A9-401F-8CAA-92D24178CDA9Q40943811-DA3DC9D3-434D-4D20-B8C4-94E0ACA12B14Q40944046-E8B7807A-32B9-47B9-AB1D-466BF3EC78ECQ40946911-DB66BAC2-A908-44DA-B135-FC01C0037FF9Q41867252-7FED81E3-E65B-4421-8DB2-0FC823C44F8FQ44910666-4B98E356-A389-4C9C-8B1E-614E853689FF
P2860
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Compound 64716, a new synthetic antibacterial agent.
@en
type
label
Compound 64716, a new synthetic antibacterial agent.
@en
prefLabel
Compound 64716, a new synthetic antibacterial agent.
@en
P2093
P2860
P356
P1476
Compound 64716, a new synthetic antibacterial agent.
@en
P2093
P2860
P304
P356
10.1128/AAC.4.4.415
P407
P577
1973-10-01T00:00:00Z